照顧一位肺腺癌個案接受免疫治療引發相關皮膚副作用之護理經驗

Nursing Experience of a Lung Cancer Patient Experiencing Receiving Immunotherapy-Related Skin Side Effects

江珮蓁(Pei-Zhen Jiang)；黃秀霖(Hsiu-Lin Huang)

肺癌 ； 免疫相關副作用 ； 皮膚完整性受損 ； immune-related adverse events ； irAEs ； impaired skin integrity ； lung cancer

志為護理-慈濟護理雜誌

22卷3期（2023 / 06 / 01）

118 - 125

繁體中文;英文

本文為描述一位肺腺癌個案因接受免疫治療引發皮膚相關副作用的照護經驗。於2021/3/15-5/3照護期間，以Gordon十一項健康功能性評估，確立有皮膚完整性受損、自我照顧能力不足及身體心像紊亂等健康問題。於護理過程建立治療性關係，教導傷口換藥、自我照顧技巧及提供疾病照顧資訊，整合個管師、傷造師、整外醫師及復健師跨團隊合作，幫助重建信心與增進自我照顧能力，並以正向態度因應疾病與治療階段。

This article is about the skin-related symptoms of a lung adenocarcinoma cancer patient who received treatment after receiving treatment. From March 15, 2021 to May 3, 2021, based on the Gordon 11 health functional assessment system, we establish that the patient has health problems, such as impaired skin integrity, lack of self-care ability, and body image disturbance. Therefore, by establishing a well good professional relationship, we taught the patient wound dressing, self-care skills, and provided disease care information, while This was achieved through integrating a multi-disciplinary team, which included case managers, wound care nurses, plastic surgeons, and physical therapists to help the patient rebuild confidence, learn self-care skills, and maintain a positive attitude towards his illness and throughout his treatment.

1. 姜亭妤,簡淑慧,徐鴻智,陳淑卿(2018)。心理調節措施在癌症患者身體心像改變及情緒困擾之成效─系統性文獻回顧。長庚護理，29(3)，350-366。
   連結：
2. 羅永鴻,邱昭華(2021)。非小細胞肺癌之免疫治療。臨床醫學月刊，87(6)，367-372。
   連結：
3. Campbell, K. L.,Winters-Stone, K. M.,Wiskemann, J.,May, A. M.,Schwartz, A. L.,Courneya, K. S.,Schmitz, K. H.(2019).Exercise guidelines for cancer survivors: Consensus statement from international multidisciplinary roundtable.Medicine & Science in Sports & Exercise,51(11),2375-2390.
4. Haanen, J. B. A. G.,Carbonnel, F.,Robert, C.,Kerr, K. M.,Peters, S.,Larkin, J.,Jordan, K.(2017).Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and followup.Annals of Oncology,28,iv119-iv142.
5. Kohanim, S.,Palioura, S.,Saeed, H. N.,Akpek, E. K.,Amescua, G.,Basu, S.,Chodosh, J.(2016).Stevens-Johnson syndrome/toxic epidermal necrolysis- A comprehensive review and guide to therapy. I. systemic disease.The Ocular Surface,14(1),2-19.
6. Rosero, I. D.,Ramírez-Vélez, R.,Martínez-Velilla, N.,Cede o-Veloz, B. A.,Morilla, I.,Izquierdo, M.(2020).Effects of a multicomponent exercise program in older adults with non-small-cell lung cancer during adjuvant/palliative treatment: An intervention study.Journal of Clinical Medicine,9(3),862.
7. Trommel, N.,Hofland, H. W.,Van Komen, R. S.,Dokter, J.,Van Baar, M. E.(2019).Nursing problems in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome in a Dutch burn centre: A 30-year retrospective study.Burns,45(7),1625-1633.
8. 吳芷儀,林逸祥(2018)。免疫檢查點抑制劑之副作用處理。彰基藥訊，26(3)，1-4。
9. 李玫萱,郭家佑,洪仁宇(2019)。非小細胞肺癌病人使用免疫檢查點抑制劑之副作用。內科學誌，30(1)，19-26。
10. 柯獻欽,鄭高珍(2018)。晚期非小細胞肺癌之化學治療與標靶治療。內科學誌，29(3)，143-152。
11. 衛生福利部統計處(2021年8月16日)．109年度死因統計．取自https://dep.mohw.gov.tw/DOS/lp-5069-113.html